<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref15">
 <mixed-citation publication-type="journal" id="cit15">
  <name>
   <surname>Zhang</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Lin</surname>
   <given-names>D.</given-names>
  </name>; 
  <name>
   <surname>Sun</surname>
   <given-names>X.</given-names>
  </name>; 
  <name>
   <surname>Curth</surname>
   <given-names>U.</given-names>
  </name>; 
  <name>
   <surname>Drosten</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Sauerhering</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Becker</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Rox</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Hilgenfeld</surname>
   <given-names>R.</given-names>
  </name>
  <article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors</article-title>. 
  <source>Science</source>
  <year>2020</year>, 
  <volume>368</volume> (
  <issue>6489</issue>), 
  <fpage>409</fpage>–
  <lpage>412</lpage>. 
  <pub-id pub-id-type="doi">10.1126/science.abb3405</pub-id>.
  <pub-id pub-id-type="pmid">32198291</pub-id>
 </mixed-citation>
</ref>
